US Patent Issued to SANTEN PHARMACEUTICAL, SINGAPORE HEALTH SERVICES on Oct. 27 for "Use of valproic acid for reducing post-operative scarring following a glaucoma surgery" (Singaporean Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,394, issued on Oct. 27, was assigned to SANTEN PHARMACEUTICAL Co. LTD. (Osaka, Japan) and SINGAPORE HEALTH SERVICES PTE LTD (Singapore).

"Use of valproic acid for reducing post-operative scarring following a glaucoma surgery" was invented by Li Fong Seet (Singapore) and Tina Tzee Ling Wong (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of valproic acid for reducing post-operative scarring following a glaucoma surgery. In one embodiment, the glaucoma surgery is glaucoma filtering surgery, which comprises creating a subconjunctival bleb. In another embodiment, the glaucoma surgery is minimally invasi...